Some therapeutic sectors saw their compound annual growth rate drop 10% or more, deviating from long-term trends. Sales should return to normal growth trajectories as backlogs in procedures continue to clear out.
Merck executives share their strategy for embedding health equity across the pharma value chain.
And How Stakeholders Can, Literally, Save the World
Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.
New Predictions on COVID-19 Vaccines and Herd Immunity
How COVID-19 case counts and vaccines may get us back to normalcy by June.
Software-only products providing free-standing treatment represent a key healthcare opportunity for incumbents.